Clinical Trials Browser

INDUSTRY × tisotumab vedotin × Tumor-Agnostic × Clear all

NCT05866354 2023-11-27

To Evaluate Pharmacokinetics of Tisotumab Vedotin in Chinese Subjects With Metastatic or Recurrent Solid Malignancies

Phase 1 Completed

Neoplasm Metastasis